Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial - PubMed (original) (raw)
Clinical Trial
. 1998 Nov 11;280(18):1596-600.
doi: 10.1001/jama.280.18.1596.
Affiliations
- PMID: 9820262
- DOI: 10.1001/jama.280.18.1596
Clinical Trial
Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial
S B Heymsfield et al. JAMA. 1998.
Abstract
Context: Hydroxycitric acid, the active ingredient in the herbal compound Garcinia cambogia, competitively inhibits the extramitochondrial enzyme adenosine triphosphate-citrate (pro-3S)-lyase. As a citrate cleavage enzyme that may play an essential role in de novo lipogenesis inhibition, G cambogia is claimed to lower body weight and reduce fat mass in humans.
Objective: To evaluate the efficacy of G cambogia for body weight and fat mass loss in overweight human subjects.
Design: Twelve-week randomized, double-blind, placebo-controlled trial.
Setting: Outpatient weight control research unit.
Participants: Overweight men and women subjects (mean body mass index [weight in kilograms divided by the square of height in meters], approximately 32 kg/m2).
Intervention: Subjects were randomized to receive either active herbal compound (1500 mg of hydroxycitric acid per day) or placebo, and both groups were prescribed a high-fiber, low-energy diet. The treatment period was 12 weeks. Body weight was evaluated every other week and fat mass was measured at weeks 0 and 12.
Main outcome measures: Body weight change and fat mass change.
Results: A total of 135 subjects were randomized to either active hydroxycitric acid (n = 66) or placebo (n = 69); 42 (64%) in the active hydroxycitric acid group and 42 (61%) in the placebo group completed 12 weeks of treatment (P = .74). Patients in both groups lost a significant amount of weight during the 12-week treatment period (P<.001); however, between-group weight loss differences were not statistically significant (mean [SD], 3.2 [3.3] kg vs 4.1 [3.9] kg; P = .14). There were no significant differences in estimated percentage of body fat mass loss between treatment groups, and the fraction of subject weight loss as fat was not influenced by treatment group.
Conclusions: Garcinia cambogia failed to produce significant weight loss and fat mass loss beyond that observed with placebo.
Comment in
- Garcinia cambogia for weight loss.
Badmaev V, Majeed M, Conte AA. Badmaev V, et al. JAMA. 1999 Jul 21;282(3):233-4; author reply 235. doi: 10.1001/jama.282.3.233. JAMA. 1999. PMID: 10422986 No abstract available. - Garcinia cambogia for weight loss.
Schaller JL. Schaller JL. JAMA. 1999 Jul 21;282(3):234; author reply 235. JAMA. 1999. PMID: 10422987 No abstract available.
Similar articles
- Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.
Hayamizu K, Ishii Y, Kaneko I, Shen M, Okuhara Y, Shigematsu N, Tomi H, Furuse M, Yoshino G, Shimasaki H. Hayamizu K, et al. Curr Ther Res Clin Exp. 2003 Sep;64(8):551-67. doi: 10.1016/j.curtheres.2003.08.006. Curr Ther Res Clin Exp. 2003. PMID: 24944404 Free PMC article. - An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management.
Preuss HG, Rao CV, Garis R, Bramble JD, Ohia SE, Bagchi M, Bagchi D. Preuss HG, et al. J Med. 2004;35(1-6):33-48. J Med. 2004. PMID: 18084863 Review. - Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans.
Márquez F, Babio N, Bulló M, Salas-Salvadó J. Márquez F, et al. Crit Rev Food Sci Nutr. 2012;52(7):585-94. doi: 10.1080/10408398.2010.500551. Crit Rev Food Sci Nutr. 2012. PMID: 22530711 Review. - IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.
Chong PW, Beah ZM, Grube B, Riede L. Chong PW, et al. Phytother Res. 2014 Oct;28(10):1520-6. doi: 10.1002/ptr.5158. Epub 2014 May 2. Phytother Res. 2014. PMID: 24797657 Free PMC article. Clinical Trial. - Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity.
Vasques CA, Rossetto S, Halmenschlager G, Linden R, Heckler E, Fernandez MS, Alonso JL. Vasques CA, et al. Phytother Res. 2008 Sep;22(9):1135-40. doi: 10.1002/ptr.2323. Phytother Res. 2008. PMID: 18729243 Clinical Trial.
Cited by
- Aquaporins (AQPs) as a marker in the physiology of inflammation and its interaction studies with garcinol.
Kalita A, Das M. Kalita A, et al. Inflammopharmacology. 2024 Apr;32(2):1575-1592. doi: 10.1007/s10787-023-01412-9. Epub 2024 Jan 24. Inflammopharmacology. 2024. PMID: 38267609 - Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie-Restricted Diet.
Tutunchi H, Arefhosseini S, Nomi-Golzar S, Ebrahimi-Mameghani M. Tutunchi H, et al. Int J Clin Pract. 2023 Jul 12;2023:6492478. doi: 10.1155/2023/6492478. eCollection 2023. Int J Clin Pract. 2023. PMID: 37476001 Free PMC article. Clinical Trial. - Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO-2022).
Pepe RB, Lottenberg AM, Fujiwara CTH, Beyruti M, Cintra DE, Machado RM, Rodrigues A, Jensen NSO, Caldas APS, Fernandes AE, Rossoni C, Mattos F, Motarelli JHF, Bressan J, Saldanha J, Beda LMM, Lavrador MSF, Del Bosco M, Cruz P, Correia PE, Maximino P, Pereira S, Faria SL, Piovacari SMF. Pepe RB, et al. Diabetol Metab Syndr. 2023 Jun 9;15(1):124. doi: 10.1186/s13098-023-01037-6. Diabetol Metab Syndr. 2023. PMID: 37296485 Free PMC article. Review. - Physiological and pathological roles of lipogenesis.
Jeon YG, Kim YY, Lee G, Kim JB. Jeon YG, et al. Nat Metab. 2023 May;5(5):735-759. doi: 10.1038/s42255-023-00786-y. Epub 2023 May 4. Nat Metab. 2023. PMID: 37142787 Review. - Anti-Inflammatory Effect of Garcinol Extracted from Garcinia dulcis via Modulating NF-κB Signaling Pathway.
Chantree P, Martviset P, Thongsepee N, Sangpairoj K, Sornchuer P. Chantree P, et al. Nutrients. 2023 Jan 22;15(3):575. doi: 10.3390/nu15030575. Nutrients. 2023. PMID: 36771283 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials